Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Katerina Chatzidionysiou

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Articles (9)

Year:

2026

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (15)

Carl Turesson

Lund University

SWEDEN

View details

Ingrid Demmelmaier

Associate Professor

Uppsala University

SWEDEN

View details

Patrick Verschueren

Full Professor

Katholieke Universiteit Leuven

BELGIUM

View details

Ingrid Lundberg

Professor

Karolinska Institutet

SWEDEN

View details

Helena Forsblad-d'Elia

Professor, Senior Consultant

University of Gothenburg, Sahlgrenska Academy

SWEDEN

View details

Denis Mulleman

Professor

Université de Tours

FRANCE

View details

Alf Kastbom

Linköping University

SWEDEN

View details

Daniela Di Giuseppe

Karolinska University Hospital

SWEDEN

View details

Arnold Vulto

Researcher

Erasmus University Rotterdam

NETHERLANDS

View details

Johan Askling

Professor

Karolinska Institutet

SWEDEN

View details

Elisabet Lindqvist

Lund University

SWEDEN

View details

Benedicte Delcoigne

Karolinska Institutet

SWEDEN

View details

Theodora Manolakou

Karolinska Institutet

SWEDEN

View details

Meliha Kapetanovic

adj professor

Lund University

SWEDEN

View details

susanne pettersson

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katerina Chatzidionysiou

Research Interests

Explore related searches

Articles (9)

Whole-blood transcriptomics identifies a distinct metabolic and inflammatory signature in lupus arthritis compared with rheumatoid arthritis

Patterns and changes in lifestyle habits of patients with rheumatoid arthritis during the first three years post-diagnosis

Multiple DMARD discontinuations in rheumatoid arthritis: how often and in what patients? Results from a national clinical RA register

Effectiveness of janus kinase inhibitors compared with biologic disease modifying anti‐rheumatic drugs on pain reduction in rheumatoid arthritis

Effect of glucocorticoids for the management of immune-related adverse events on outcome in melanoma patients treated with immunotherapy—a retrospective and biomarker study

Evaluation of an individually tailored smoking-cessation intervention for patients with rheumatoid arthritis in an outpatient clinic

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

The Impact of Immunomodulating Treatment on the Immunogenicity of COVID-19 Vaccines in Patients with Immune-mediated Inflammatory Rheumatic Diseases Compared to Healthy Controls. a Swedish Nationwide Study (COVID19-REUMA)

Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden

Collaborators (15)

Carl Turesson

Ingrid Demmelmaier

Patrick Verschueren

Ingrid Lundberg

Helena Forsblad-d'Elia

Denis Mulleman

Alf Kastbom

Daniela Di Giuseppe

Arnold Vulto

Johan Askling

Elisabet Lindqvist

Benedicte Delcoigne

Theodora Manolakou

Meliha Kapetanovic

susanne pettersson

Make your next move.